Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DYN alerts

About Doug Kerr

Dyne Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Doug Kerr was appointed chief medical officer. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John G. Cox (CEO and Board Member), Josh Brumm (CEO), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.

“On September 3, 2024, the Company issued a press release announcing the hiring of Doug Kerr as chief medical officer, Johanna Friedl-Naderer as chief commercial officer and Lucia Celona as chief human resources officer and the resignations of Dr. McNeill, Ms. High and Wildon Farwell, the chief medical officer.”
Dyne Therapeutics, Inc. Form 8-K, filed September 3, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Dyne Therapeutics, Inc.

Recent activity